LENSAR, Inc. (NASDAQ:LNSR – Get Rating) Director Aimee S. Weisner purchased 22,153 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The stock was bought at an average cost of $2.59 per share, for a total transaction of $57,376.27. Following the purchase, the director now directly owns 37,638 shares in […]
LENSAR (NASDAQ:LNSR – Get Rating) announced its quarterly earnings results on Monday. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.13), MarketWatch Earnings reports. LENSAR had a negative net margin of 56.32% and a negative return on equity of 44.43%. The company had revenue of $8.25 […]
Increased ALLY® Adaptive Cataract Treatment System installed base to 19 systems with a backlog of additional 13 systems as of May 12, 2023
U.S. procedure volumes increased 13% over first. | May 15, 2023
LENSAR (NASDAQ:LNSR – Get Rating) is scheduled to be posting its quarterly earnings results before the market opens on Monday, May 15th. LENSAR (NASDAQ:LNSR – Get Rating) last posted its quarterly earnings results on Thursday, March 16th. The company reported ($0.24) EPS for the quarter. LENSAR had a negative net margin of 56.32% and a […]
LENSAR, Inc. (NASDAQ:LNSR – Get Rating)’s share price fell 2.3% during trading on Monday . The stock traded as low as $2.58 and last traded at $2.58. 3,950 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 18,436 shares. The stock had previously closed at $2.64. LENSAR Trading […]